Oncternal Therapeutics Inc Asset Resilience Ratio

Latest as of September 2024: 9.61%

Oncternal Therapeutics Inc asset resilience ratio. Oncternal Therapeutics Inc (ONCT) has an Asset Resilience Ratio of 9.61% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Oncternal Therapeutics Inc (ONCT) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$1.50 Million

Cash + Short-term Investments

Total Assets

$15.60 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Oncternal Therapeutics Inc (2007–2023)

Asset resilience ratio of Oncternal Therapeutics Inc from 2007 to 2023. This chart shows how Oncternal Therapeutics Inc's Asset Resilience Ratio has changed over time. Read how much debt does Oncternal Therapeutics Inc carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Oncternal Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Oncternal Therapeutics Inc asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$1.50 Million	9.61%
Total Liquid Assets	$1.50 Million	9.61%

Asset Resilience Insights

Limited Liquidity: Oncternal Therapeutics Inc maintains only 9.61% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Oncternal Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Oncternal Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Oncternal Therapeutics Inc Asset Resilience Ratio by Year (2007–2023)

Oncternal Therapeutics Inc asset resilience ratio by year from 2007 to 2023. The table below shows the annual Asset Resilience Ratio data for Oncternal Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	75.03%	$27.56 Million	$36.73 Million	+36.31pp
2022-12-31	38.72%	$26.58 Million	$68.65 Million	--
2021-12-31	0.00%	$0.00	$93.58 Million	--
2018-12-31	0.64%	$200.00K	$31.32 Million	-60.10pp
2017-12-31	60.74%	$28.08 Million	$46.24 Million	+7.85pp
2016-12-31	52.89%	$12.96 Million	$24.50 Million	+5.44pp
2015-12-31	47.45%	$15.20 Million	$32.03 Million	-14.57pp
2014-12-31	62.02%	$31.41 Million	$50.65 Million	+60.74pp
2013-12-31	1.28%	$200.00K	$15.61 Million	-12.64pp
2012-12-31	13.92%	$8.04 Million	$57.77 Million	+0.25pp
2011-12-31	13.68%	$10.70 Million	$78.18 Million	+12.98pp
2010-12-31	0.70%	$450.00K	$64.25 Million	-14.59pp
2009-12-31	15.29%	$8.82 Million	$57.72 Million	+13.29pp
2008-12-31	2.00%	$2.16 Million	$108.11 Million	-4.15pp
2007-12-31	6.14%	$9.81 Million	$159.73 Million	--

pp = percentage points

About Oncternal Therapeutics Inc

NASDAQ:ONCT USA Biotechnology

Market Cap

$1.56 Million

Market Cap Rank

#30285 Global

#6176 in USA

Share Price

$0.53

Change (1 day)

+0.00%

52-Week Range

$0.53 - $0.53

All Time High

$3533.60